5-Amino-1MQ Preclinical Safety Profile: What the Literature Reports
As a novel small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), 5-amino-1MQ has generated significant interest across metabolic and cellular research disciplines. This technical overview synthesizes published preclinical literature regarding the compound's safety parameters, metabolic effects, and laboratory handling protocols. All data presented herein are derived strictly from in vitro assays and animal models to guide qualified laboratory personnel in controlled experimental settings.
Quick answer
As a novel small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), 5-amino-1MQ has generated significant interest across metabolic and cellular research disciplines. This technical overview synthesizes published preclinical literature regarding the compound's safety parameters, metabolic effects, and laboratory handling protocols. All data presented herein are derived strictly from in vitro assays and animal models to guide qualified laboratory personnel in controlled experimental settings.
Key takeaways
- 5-Amino-1-methylquinolinium ([5-amino-1MQ](/research-peptides/5-amino-1mq)) is a membrane-permeable small molecule engineered to selectively inhibit nicotinamide N-methyltransferase (NNMT).
- Primary literature evaluating [5-amino-1mq safety research](/research-peptides/5-amino-1mq-preclinical-safety-profile) relies on rodent models of diet-induced obesity, metabolic dysfunction, and tissue regeneration.
- Detailed histological and enzymatic evaluations from published rodent studies provide key baseline data regarding organ-specific safety parameters.
- Because NNMT utilizes S-adenosylmethionine (SAM) as its primary methyl donor, inhibiting the enzyme directly impacts cellular methyl donor availability.
Biochemical Structure and Mechanism of NNMT Inhibition
5-Amino-1-methylquinolinium (5-amino-1MQ) is a membrane-permeable small molecule engineered to selectively inhibit nicotinamide N-methyltransferase (NNMT). NNMT is a cytosolic enzyme predominantly expressed in adipose tissue, liver, and skeletal muscle cells, where it plays a central regulatory role in cellular energy homeostasis and nutrient partitioning.
Under baseline physiological conditions, NNMT catalyzes the methylation of nicotinamide (NAM) using S-adenosylmethionine (SAM) as a methyl donor, producing 1-methylnicotinamide (1-MNA) and S-adenosylhomocysteine (SAH). Because NAM serves as a direct salvage precursor for nicotinamide adenine dinucleotide (NAD+), elevated NNMT activity depletes intracellular NAD+ pools and compromises mitochondrial respiration.
In vitro assays demonstrate that 5-amino-1MQ functions as a competitive, small-molecule inhibitor of NNMT. By blocking NNMT activity in preclinical model systems, researchers observe a preservation of intracellular NAM, an enhancement of NAD+ synthesis through the salvage pathway, and an elevation in cellular energy expenditure. High-purity compounds such as 5-amino-1MQ 5mg enable investigators to study these specific enzymatic pathways without non-specific off-target interference.
Overview of Published 5-Amino-1MQ Safety Research in Animal Models
Primary literature evaluating 5-amino-1mq safety research relies on rodent models of diet-induced obesity, metabolic dysfunction, and tissue regeneration. In these preclinical trials, subjects receiving systemic administration of 5-amino-1MQ demonstrated high acute and sub-chronic tolerability across designated dosage ranges.
In murine studies investigating high-fat diet regimes, daily administration of 5-amino-1MQ over multi-week periods did not elicit signs of overt clinical toxicity, behavioral changes, or premature mortality. Weight reduction observed in animal cohorts was attributed to reduced adipocyte size and accelerated lipid oxidation rather than hypophagia, systemic toxicity, or gastrointestinal distress.
Importantly, preclinical safety data confirm that NNMT inhibition by 5-amino-1MQ does not alter central nervous system activity, as the molecule exhibits low blood-brain barrier permeability under baseline experimental conditions. Consequently, behavioral open-field tests in rodent models revealed no alterations in locomotor activity or anxiety-like responses.
Hepatic, Renal, and Systemic Toxicology Parameters
Detailed histological and enzymatic evaluations from published rodent studies provide key baseline data regarding organ-specific safety parameters. Serum biochemistry panels collected at trial endpoints demonstrate consistent stability across major organ biomarkers.
Hepatic function markers, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP), remained within normal reference intervals in mice treated with selective NNMT inhibitors compared to vehicle controls. Liver histology confirmed reduced hepatic steatosis without signs of necrosis, cellular inflammation, or fibrotic changes.
Similarly, renal safety biomarkers—specifically blood urea nitrogen (BUN) and serum creatinine—showed no significant deviation from control baselines. Histopathological examination of renal cortical and medullary tissues revealed intact glomeruli and tubules without inflammatory infiltration. These preclinical findings suggest that 5-amino-1MQ does not induce acute nephrotoxicity within tested experimental parameters.
Impact on Methylation Homeostasis and Epigenetic Dynamics
Because NNMT utilizes S-adenosylmethionine (SAM) as its primary methyl donor, inhibiting the enzyme directly impacts cellular methyl donor availability. In preclinical research models, high NNMT expression correlates with SAM depletion and reduced histone methylation, leading to altered gene expression patterns associated with metabolic dysfunction.
In vitro studies indicate that treatment with 5-amino-1MQ increases the cellular SAM/SAH ratio in adipocytes and myoblasts. This restoration of methyl donor pools supports normal epigenetic regulation, promoting hypermethylation of specific promoter regions that suppress lipogenic gene profiles.
Crucially, safety investigations evaluating total cellular methylation dynamics indicate that 5-amino-1MQ does not cause global DNA hypermethylation or unselective methyl accumulation. Instead, the compound normalizes SAM availability, allowing methyltransferases to function within baseline physiological limits without inducing epigenetic toxicity in animal tissue models.
Comparative Preclinical Profile: 5-Amino-1MQ and Related Metabolic Modulators
When evaluating metabolic research compounds in preclinical study designs, researchers frequently compare 5-amino-1MQ to other small molecules and peptides targeting energetic pathways. Distinct mechanisms exist between direct enzymatic inhibitors like 5-amino-1MQ and upstream pathway activators.
For example, MOTS-c is a mitochondrial-derived peptide that regulates nuclear gene expression and enhances insulin sensitivity via the folate-AICAR-AMPK axis. In contrast, AICAR acts as a direct analog of adenosine monophosphate (AMP) to stimulate AMP-activated protein kinase (AMPK) directly. While both MOTS-c and AICAR activate broad cellular energy-sensing cascades, 5-amino-1MQ targets cytosolic substrate conservation by inhibiting NNMT directly.
Because 5-amino-1MQ operates downstream of receptor-mediated cascades, its preclinical safety profile lacks the broad cardiovascular or hemodynamic fluctuations sometimes noted with non-selective metabolic stimulators. Researchers interested in building comprehensive metabolic experimental panels can explore the full range of reagents in the PX1 catalog of research peptides and small molecules.
Analytical Quality Control and Purity Verification Standards
Reliable preclinical research requires rigorous chemical purity and batch consistency. Inconsistent reagents or chemical impurities can introduce confounding variables, invalidating toxicological and metabolic measurements in laboratory models.
PX1 Research ensures that every batch of 5-amino-1MQ undergoes comprehensive analytical validation. Products are manufactured in USA-based, GMP-compliant facilities and undergo independent ISO 17025 laboratory verification.
Quality control verification includes high-performance liquid chromatography (HPLC) to confirm purity exceeding 98%, mass spectrometry (MS) to verify molecular mass and chemical identity, and Chromogenic LAL assays to ensure low endotoxin levels (<0.05 EU/mg). Researchers can review lot-specific analytical reports directly by accessing our verified Certificate of Analysis (COA) database.
Laboratory Safety, Chemical Handling, and Disposal Protocols
5-Amino-1MQ is a synthetic small-molecule chemical intended strictly for in vitro laboratory research and preclinical animal studies. It is not intended for human, clinical, or veterinary applications. Qualified laboratory personnel must implement standard chemical safety precautions during receiving, handling, and reconstitution.
Personal protective equipment (PPE) must be worn at all times when handling dry powder or concentrated solutions, including nitrile gloves, safety glasses with side shields, and a laboratory coat. Powder handling should be conducted inside a certified chemical fume hood or biosafety cabinet to prevent accidental inhalation or ocular contact.
In the event of a spill, isolate the area, apply dry absorbent material for liquid spills, or carefully sweep powder into an appropriate chemical waste container using non-sparking tools. Neutralize the area with standard laboratory detergent and water. For complete chemical hazards, risk statements, and disposal guidelines, consult the product Safety Data Sheet (SDS). When preparing working stock solutions, researchers should consult the PX1 reconstitution calculator to ensure accurate molar concentration measurements.
Experimental Guidelines for In Vitro and In Vivo Solubilization
Proper reconstitution and storage are critical to maintaining chemical integrity and preventing precipitate formation during assay execution. 5-Amino-1MQ exhibits high solubility in organic solvents such as dimethyl sulfoxide (DMSO) and moderate solubility in aqueous buffers depending on pH.
For in vitro cell culture studies, stock solutions are typically dissolved in high-purity DMSO and subsequently diluted into culture media to achieve final working concentrations (typically 1–10 µM). Ensure that the final DMSO concentration in cell culture assays remains below 0.1% (v/v) to avoid solvent-induced cellular toxicity.
For in vivo rodent models, vehicle formulations commonly utilize sterile physiological saline (0.9% NaCl) or phosphate-buffered saline (PBS) containing low co-solvent percentages (e.g., 5–10% DMSO, PEG300, or Tween-80) to maintain compound stability in solution. Lyophilized powder should be stored at -20°C in a desiccated container away from light, while liquid working stocks should be aliquoted and stored at -80°C to minimize freeze-thaw degradation.
Current Preclinical Research Frontiers and Future Scope
Preclinical investigation into NNMT inhibition extends beyond primary metabolic parameters. Emerging studies explore the utility of 5-amino-1MQ in muscle stem cell proliferation, age-related tissue regeneration, and cellular senescence models.
In vitro models of senescent muscle stem cells show that NNMT expression increases with cellular age, dampening regenerative capacity. Application of 5-amino-1MQ in these assays restores NAD+ levels, boosting myoblast proliferation and differentiation potential without inducing oncogenic transformation.
Additional research explores the compound's impact on extracellular matrix remodeling and fibrosis in rodent models. To stay updated on peer-reviewed literature and experimental protocols involving metabolic regulators, visit the PX1 research library.
Institutional Purchasing and Compliance Mandates
PX1 Research maintains strict adherence to federal and international chemical compliance standards. 5-Amino-1MQ is offered strictly as a research chemical reagent for supply to university laboratories, contract research organizations (CROs), and institutional research facilities.
Orders are packaged with secure tamper-evident seals and shipped directly from our USA distribution hubs in California and Arizona. Same-day dispatch is available for orders confirmed Monday through Friday before standard cutoff times.
Principal investigators and procurement managers seeking bulk quantities or custom analytical packaging can establish verified institutional accounts through our dedicated wholesale portal.
Frequently Asked Questions
What is the primary molecular target evaluated in 5-amino-1mq safety research?
5-Amino-1MQ is studied primarily as a selective inhibitor of nicotinamide N-methyltransferase (NNMT), a cytosolic enzyme involved in nicotinamide methylation, methyl donor depletion, and energy regulation.
Has 5-amino-1MQ demonstrated hepatotoxicity in preclinical animal models?
Published rodent studies report stable hepatic enzyme markers (ALT, AST, ALP) and healthy liver tissue histology across standard experimental dosage ranges, indicating a favorable hepatic safety profile in preclinical models.
What PPE is required when handling 5-amino-1MQ in a laboratory setting?
Laboratory personnel should wear nitrile gloves, protective eyewear, and a lab coat. Reconstitution and powder transfers must take place inside a chemical fume hood to prevent inhalation or dermal contact.
How should 5-amino-1MQ be solubilized for cell culture assays?
5-Amino-1MQ dissolves readily in DMSO. Concentrated DMSO stock solutions should be diluted into culture media so that the final solvent concentration remains under 0.1% v/v to eliminate vehicle toxicity.
Does 5-amino-1MQ alter central nervous system activity in rodent models?
In preclinical animal studies, 5-amino-1MQ exhibited low blood-brain barrier permeability and did not alter baseline behavioral or locomotor parameters in open-field testing.
How does PX1 Research verify the quality and purity of 5-amino-1MQ?
Every lot manufactured in our USA facilities undergoes third-party ISO 17025 laboratory testing using HPLC (purity >98%), Mass Spectrometry (molecular weight confirmation), and Chromogenic LAL assays for endotoxin verification.
Where can safety data and hazard information for 5-amino-1MQ be found?
Detailed chemical hazards, handling steps, and spill disposal instructions are outlined in the official product Safety Data Sheet (SDS) accessible on the PX1 website.
How does 5-amino-1MQ differ from metabolic peptides like MOTS-c?
While MOTS-c acts as a mitochondrial-derived peptide influencing nuclear transcription factors, 5-amino-1MQ is a small-molecule direct inhibitor of the cytosolic enzyme NNMT, conserving NAD+ precursors directly.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.